1[1]Munoz N, Bosch F X, Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer[J]. N Engl J Med,2003,348(6):518 - 527.
2[2]Einstein M H, Goldberg G L. Human papillomavirus and cervical neoplasia[J]. Cancer Invest ,2002,20(7 - 8): 1080 - 1085.
3[3]Bosch F X, Munoz N. The viral etiology of cervical cancer[J].Virus Res ,2002,89(2): 183 - 190.
4[4]Dell G, Gaston K. Human papillomaviruses and their role in cervical cancer[J]. Cell Mol Life Sci,2001,58(12 - 13) :1923 -1942.
5[5]Senior K. Cervical cancer research focuses on the HPV E7 gene[J]. Lancet,2002,3(10) :585.
6[6]DeFilippis R A, Goodwin E C, Wu L, et al. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells[J]. J Virol,2003,77(2): 1551 - 1563.
7[7]Knebel D M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections[J]. Eur J Cancer,2002,38(17) :2229 - 2242.
8[8]Beral V, Hermon C, Kay C, et al. Mortality associated with oral contraceptive use:25 year follow up of 46 000 women from Royal College of General Practitioners' oral contraception study[J]. BMJ, 1999,318(7176) :96 - 100.
9[9]Yuan F, Auborn K, James C. Altered growth and viral gene expression in human papillomavirus type 16-containing cancer cell lines treated with progesterone[J]. Cancer Invest, 1999,17(1):19-29.
10[10]Knebel D M, Spitkovsky D, Ridder R. Interactions between steroid hormones and viral oneogenes in the pathogenesis of cervical cancer[J]. Verh Dtsch Ges Pathol,1997,81:233 - 239.
